￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
MET inhibitor-capmatinib for the treatment of advanced non-small cell lung cancer

2025-10-19 11:44:20

Check Details
What is capmatinib? Is the effect really that good?

2025-10-19 11:44:20

Check Details
Rubitidine combined with irinotecan in the treatment of relapsed small cell lung cancer

2025-10-19 11:44:20

Check Details
Small cell lung cancer is finally looking forward to a new chemotherapy drug - rupitidine

2025-10-19 11:44:20

Check Details
U.S. FDA approves Rybrevant for the treatment of metastatic non-small cell lung cancer _ Kanghule

2025-10-19 11:44:20

Check Details
The first RET inhibitor platinib in China is on the market!

2025-10-19 11:44:20

Check Details
How should I take icotinib to treat lung cancer? How long does it take for resistance to develop?

2025-10-19 11:44:20

Check Details
RET inhibitor with 85% effectiveness-serpatinib

2025-10-19 11:44:20

Check Details
The latest data on the new anti-cancer drug entrectinib are released, with an effective rate of 100%!

2025-10-19 11:44:20

Check Details
How long can a person with advanced lung cancer live after taking the targeted drug gefitinib? How much does a box cost in Hubei?

2025-10-19 11:44:20

Check Details
Mobotinib, the second targeted drug, approved to treat non-small cell lung cancer

2025-10-19 11:44:20

Check Details
What is Mobotinib? How to buy it?

2025-10-19 11:44:20

Check Details
Category
相关知识